Stawowy Philipp, Kappert Kai
Department of Medicine/Cardiology, Deutsches Herzzentrum Berlin, D-13353, Berlin, Germany.
Methods Mol Biol. 2011;768:191-206. doi: 10.1007/978-1-61779-204-5_9.
Vascular smooth muscle cell (VSMC) proliferation and migration represent key features in atherosclerosis and restenosis. The proprotein convertases (PCs) furin and PC5 are highly expressed in human atheroma and are putatively involved in vascular lesion formation via the activation of precursor proteins, essential for cell proliferation and migration. In vitro assays have identified these PCs to govern cell functions via endoproteolytic cleavage of key substrates, including pro-integrins and pro-matrix metalloproteinases. In vivo gene expression studies of furin/PC5 and their substrates demonstrate their coordinated regulation in animal models of vascular remodelling and in human atherosclerotic lesions. Here we describe in vitro and in vivo models to investigate the function of furin/PC5 in VSMCs and in vascular lesion formation. In conjunction with the development of novel PC inhibitors, this should facilitate the development of new strategies targeting PCs in cardiovascular disease.
血管平滑肌细胞(VSMC)的增殖和迁移是动脉粥样硬化和再狭窄的关键特征。前蛋白转化酶(PCs)弗林蛋白酶和PC5在人类动脉粥样硬化斑块中高表达,并推测通过激活对细胞增殖和迁移至关重要的前体蛋白参与血管病变形成。体外实验已证实这些PCs通过对关键底物(包括前整合素和前基质金属蛋白酶)进行内蛋白水解切割来调控细胞功能。弗林蛋白酶/PC5及其底物的体内基因表达研究表明,它们在血管重塑动物模型和人类动脉粥样硬化病变中受到协同调控。在此,我们描述了体外和体内模型,以研究弗林蛋白酶/PC5在血管平滑肌细胞和血管病变形成中的功能。结合新型PC抑制剂的研发,这应有助于开发针对心血管疾病中PCs的新策略。